Disclaimer: This site analyses public FDA records. It is not medical advice. If you feel unwell, contact a healthcare professional immediately.
Supplement Safety Checker
Notice: Official Public Record

South Texas Botanicals FDA Warning (2018)

Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on March 29, 2018

MODERATE SEVERITY Dallas District Office 2018
Disclaimer: This report is an analysis of a public FDA warning letter. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately.

Executive Summary

The FDA issued a warning letter to South Texas Botanicals on March 29, 2018 citing labeling violations. The letter was issued by Dallas District Office.

Labeling Violations

Detailed Analysis

False Claims and Regulatory Violations

“Try this formula for mouth sores, gum disease, toothaches, cavities, sore throat. . .”

“[I]ncrease platelet count, preventing the need for a blood transfusion. . .”

“It appears to have been effective to increase platelet count, preventing the need for a blood transfusion . . .to use along when dealing withlyme (sic) disease. . . “

Potential Health Risks

Consumers should be aware of potential risks associated with products from South Texas Botanicals.

Regulatory Context

“[A]n aid to relieve irritation in the respirtory (sic) tract, lungs and bronchial, asbronchitis, allergies . . .”

You failed to establish specifications for each component that you use in the manufacture of a dietary supplement. Specifically, you failed to establish the following: an identity specification; specifications to ensure purity, strength and composition of dietary supplements manufactured using the components are met; and specifications that establish the limits on those types of contamination that may adulterate or may lead to adulteration of the finished batch of the dietary supplement to ensure the quality of the dietary supplement, as required by 21 CFR 111.70(b)(1)-(3).

Youfailed to establish specifications for each dietary supplement that you manufacture for the identity, purity, strength, and composition of the finished batch of the dietary supplement and for limits on those types of contamination that may adulterate, or that may lead to adulteration of, the finished batch of the dietary supplement, as required by 21 CFR 111.70(e).

Key Entities Identified

21 CFR 111.70 21 CFR 111.70 21 CFR 111.210 Lead

Frequently Asked Questions

What did the FDA find wrong with South Texas Botanicals?
The FDA issued a warning letter citing labeling violations related to their products or manufacturing practices.
Are South Texas Botanicals products safe to use?
Based on the FDA's findings, consumers should exercise caution. The company was found to have labeling violations that may affect product safety.
What should I do if I've used South Texas Botanicals products?
If you have used products from South Texas Botanicals and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.

Source Document

This report is based on an official FDA warning letter. The original document is a public record.

View Original FDA Warning Letter
Medical Disclaimer: This report is an analysis of public FDA warning letters. It is not medical advice. If you have consumed these products and feel unwell, contact a healthcare professional immediately. You can report adverse events to the FDA MedWatch program.